265.40

4.02% -11.13

Pre-market: 265.40

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $265.40, with a volume of 333.40K. It is down -4.02% in the last 24 hours and down -4.68% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$276.53

Open:

$276.51

24h Volume:

333.40K

Relative Volume:

1.24

Market Cap:

$7.16B

Revenue:

$2.58B

Net Income/Loss:

$759.90M

P/E Ratio:

9.5068

EPS:

27.9168

Net Cash Flow:

$374.60M

1W Performance:

+0.34%

1M Performance:

-4.68%

6M Performance:

-2.20%

1Y Performance:

+7.38%

1-Day Range:

$264.23

$276.51

1-Week Range:

$260.58

$277.82

52-Week Range:

$211.43

$343.12

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1112)

Industry

Medical Devices (143)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,450

Twitter

@BioRadLifeSci

Next Earnings Date

2024-10-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	265.40	7.16B	2.58B	759.90M	374.60M	27.92
ABT Abbott Laboratories	103.99	180.70B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.44	125.40B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.14	111.88B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.17	102.80B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	79.34	45.74B	6.07B	1.06B	1.34B	1.8063

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

Mar 29, 2026

Bio-Rad Laboratories Stock: A Cornerstone in Life Sciences Tools Amid Precision Medicine Momentum - AD HOC NEWS

Mar 29, 2026

Mar 28, 2026

Is Bio Rad Laboratories Inc a cyclical or defensive stockWeekly Trade Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 28, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 28, 2026

Mar 27, 2026

Electrophoresis Reagents Market Expands with North America - openPR.com

Mar 27, 2026

Mar 26, 2026

Vanguard disaggregates holdings; Bio‑Rad Labs (NYSE: BIO) shows 0 shares - Stock Titan

Mar 26, 2026

Mar 25, 2026

Bio-Rad Laboratories Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Mar 25, 2026

Executive pay, equity plan and dual-class vote at Bio-Rad (NYSE: BIO) 2026 meeting - Stock Titan

Mar 25, 2026

BIO Technical Analysis | Trend, Signals & Chart Patterns | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill

Mar 23, 2026

Mar 21, 2026

Retail Trends: What is the long term forecast for Bio Rad Laboratories Inc. stock2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Bio-Rad Laboratories Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo

Mar 20, 2026

Disappointing Results Hurt Bio-Rad Laboratories (BIO) - Insider Monkey

Mar 20, 2026

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.

Mar 20, 2026

Mar 18, 2026

Moving Averages: Is Bio Rad Laboratories Inc likely to announce a buybackWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn

Mar 18, 2026

Capillary Electrophoresis Market size to hit $632.8 Million - openPR.com

Mar 18, 2026

Mar 17, 2026